These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7503471)

  • 1. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women.
    Genç M; Mårdh A
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):1-7. PubMed ID: 7503471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic evaluation of screening for Chlamydia trachomatis in adolescent males.
    Genç M; Ruusuvaara L; Mårdh PA
    JAMA; 1993 Nov; 270(17):2057-64. PubMed ID: 8411572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease.
    Howell MR; Gaydos JC; McKee KT; Quinn TC; Gaydos CA
    Sex Transm Dis; 1999 Oct; 26(9):519-26. PubMed ID: 10534206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening women for chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays.
    Howell MR; Quinn TC; Brathwaite W; Gaydos CA
    Sex Transm Dis; 1998 Feb; 25(2):108-17. PubMed ID: 9518379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.
    Howell MR; Quinn TC; Gaydos CA
    Ann Intern Med; 1998 Feb; 128(4):277-84. PubMed ID: 9471930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings.
    Hillis SD; Coles FB; Litchfield B; Black CM; Mojica B; Schmitt K; St Louis ME
    Sex Transm Dis; 1998 Jan; 25(1):5-11. PubMed ID: 9437777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A school-based Chlamydia control program using DNA amplification technology.
    Cohen DA; Nsuami M; Etame RB; Tropez-Sims S; Abdalian S; Farley TA; Martin DH
    Pediatrics; 1998 Jan; 101(1):E1. PubMed ID: 9417165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis: impact on human reproduction.
    Paavonen J; Eggert-Kruse W
    Hum Reprod Update; 1999; 5(5):433-47. PubMed ID: 10582782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis.
    Magid D; Douglas JM; Schwartz JS
    Ann Intern Med; 1996 Feb; 124(4):389-99. PubMed ID: 8554247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK.
    Norman JE; Wu O; Twaddle S; Macmillan S; McMillan L; Templeton A; McKenzie H; Noone A; Allardice G; Reid M
    BJOG; 2004 Nov; 111(11):1261-8. PubMed ID: 15521872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azithromycin efficacy in the treatment of Chlamydia trachomatis among detained youth.
    Beyda RM; Benjamins LJ; Symanski E; Swartz M; Risser WL; Eissa M
    Sex Transm Dis; 2014 Oct; 41(10):592-4. PubMed ID: 25211253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens.
    Guven MA; Gunyeli I; Dogan M; Ciragil P; Bakaris S; Gul M
    Arch Gynecol Obstet; 2005 Sep; 272(3):197-200. PubMed ID: 15778862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of azithromycin and doxycycline on cytokines in cells from Chlamydia trachomatis-infected women.
    Srivastava P; Bhengraj AR; Jha HC; Vardhan H; Jha R; Singh LC; Salhan S; Mittal A
    DNA Cell Biol; 2012 Mar; 31(3):392-401. PubMed ID: 21848430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis.
    Postma MJ; Welte R; van den Hoek JA; van Doornum GJ; Jager HC; Coutinho RA
    Value Health; 2001; 4(3):266-75. PubMed ID: 11705188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, open-label, multicenter study of azithromycin compared with doxycycline for treating anorectal Chlamydia trachomatis infection concomitant to a vaginal infection (CHLAZIDOXY study).
    Peuchant O; Lhomme E; Krêt M; Ghezzoul B; Roussillon C; Bébéar C; Perry F; de Barbeyrac B;
    Medicine (Baltimore); 2019 Feb; 98(7):e14572. PubMed ID: 30762806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.
    Haddix AC; Hillis SD; Kassler WJ
    Sex Transm Dis; 1995; 22(5):274-80. PubMed ID: 7502180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure).
    Dukers-Muijrers NHTM; Wolffs PFG; De Vries H; Götz HM; Heijman T; Bruisten S; Eppings L; Hogewoning A; Steenbakkers M; Lucchesi M; Schim van der Loeff MF; Hoebe CJPA
    Clin Infect Dis; 2019 Nov; 69(11):1946-1954. PubMed ID: 30689759
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.